Xeris Biopharma Holdings Inc
XERS
$7.36-0.32 (-4.17%)
Aug 18, 2025, 4:00 PM
Financials
| 52Week High | 7.72 | 52Week Low | 2.39 |
| Beta | 0.55 | Current Ratio Annual | 1.67 |
| Current Ratio Quarterly | 1.72 | Gross Margin TTM | 82.21 |
| Market Cap | 861.63M | Net Profit Margin TTM | -20.25 |
| Operating Margin TTM | -10.11 | Price To Book | 220.93 |
| Price To Sales TTM | 3.87 | Quick Ratio Annual | 1.12 |
| Quick Ratio Quarterly | 1.10 | Return On Assets TTM | -13.96 |
| Return On Equity TTM | -266.62 | Return On Investment TTM | -29.22 |
| Revenue Growth3Y | 59.98 | Revenue Growth5Y | 137.28 |
| Revenue Growth Quarterly Yoy | 47.94 | Revenue Growth TTMYoy | 29.87 |
| Revenue Per Share TTM | 1.46 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 162 | 1 | 0 | 9 | 2 | 1 | 65.47M | $217.25M |
| Mar 31, 2025 | 200(+23%) | 55(+5400%) | 16(+%) | 72(+700%) | 38(+1800%) | 31(+3000%) | 86.78M(+33%) | $469.25M(+116%) |
| Jun 30, 2025 | 199(-1%) | 21(-62%) | 24(+50%) | 78(+8%) | 57(+50%) | 37(+19%) | 86.78M(-0%) | $397.05M(-15%) |